Format

Send to

Choose Destination
Aktuelle Urol. 2007 Jul;38(4):328-30.

[Interdisciplinary recommendations on targeted therapy in the treatment of renal cell carcinoma].

[Article in German]

Author information

1
Urologische Klinik, Charité Berlin, Germany. kurt.miller@charite.de

Abstract

Recently, new data have been published on the treatment of metastasized renal cell cancer using targeted therapies. With the approval of the tyrosine kinase inhibitors Sunitinib and Sorafenib, two of these new therapies are now available in clinical practice. This has raised both new opportunities and new questions for the health care professionals involved. Here we report on a consensus conference addressing these questions with answers based on evidence from the recent literature.

PMID:
17647172
DOI:
10.1055/s-2007-980093
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center